Inflammatory Spondyloarthropathy as a Spine Mimic

Overview

Inflammatory spondyloarthropathy is a family of autoimmune conditions, with ankylosing spondylitis as the best-known member, in which the immune system attacks the joints of the spine and pelvis. Because the dominant symptom is deep, chronic low back and buttock pain, it is one of the most commonly missed mimics of ordinary degenerative spine disease. The pain pattern can look enough like a disc problem or arthritis of the spine that people spend years being treated for a mechanical issue before the true inflammatory cause is recognized.

The distinction matters because the underlying process is completely different. Degenerative back pain comes from wear on discs, joints, and ligaments. Inflammatory spondyloarthropathy comes from the immune system driving ongoing inflammation at the sacroiliac joints and the entheses, the sites where ligaments and tendons attach to bone. Left unrecognized, that inflammation can eventually lead to new bone formation that fuses spinal segments together, but it responds very well to treatments that a mechanical back problem does not need.

What causes it

Axial spondyloarthritis (the umbrella term that includes both ankylosing spondylitis and its earlier, non-radiographic stage) is an autoimmune disease in which the body's immune system mistakenly targets the sacroiliac joints and spinal entheses. The exact trigger is not fully understood, but genetics play a major role. Most people with the condition carry the HLA-B27 gene variant, although carrying the gene does not mean someone will develop the disease, and some patients with confirmed spondyloarthritis test negative for it.

The condition typically begins in the sacroiliac joints, where the spine meets the pelvis, and can progress upward into the lumbar, thoracic, and cervical spine over years. It often travels with a recognizable group of related problems, including psoriasis, inflammatory bowel disease, and inflammatory eye disease (uveitis), which is why a family or personal history of any of these conditions is an important clue. It tends to start in young adulthood, most often before age 45, and affects men somewhat more often than women, though it is increasingly recognized in women as well.

Symptoms and warning signs

The hallmark feature is inflammatory back pain, a specific pattern that differs from ordinary mechanical pain in several key ways: gradual onset before age 45, symptoms lasting three months or longer, morning stiffness lasting more than 30 minutes, improvement with exercise but not with rest, and pain that often wakes the person in the second half of the night. Pain frequently centers in the buttocks and lower back and can alternate sides. Some people also notice pain and swelling in peripheral joints such as the hips, knees, or ankles, or heel pain from inflammation where the Achilles tendon or plantar fascia attaches to bone (enthesitis).

Extra-spinal features are an important part of the picture and can appear before, during, or after the back symptoms. These include eye redness and pain from anterior uveitis, psoriasis-type skin changes, and gastrointestinal symptoms suggestive of inflammatory bowel disease. Fatigue is also common, since ongoing systemic inflammation itself is tiring, not just the pain.

Seek prompt medical evaluation if you notice new eye pain, redness, or light sensitivity, which can signal acute uveitis and needs urgent ophthalmology care, or new chest pain, shortness of breath, or an irregular heartbeat, since long-standing disease can rarely affect the heart's conduction system or the aortic valve. Seek emergency care immediately if you develop sudden loss of bladder or bowel control or saddle-area numbness, or new rapidly progressive weakness, particularly after even a minor fall. In advanced disease the spine can become rigid and brittle, so a fall that would be trivial for most people can cause an unstable spinal fracture.

How it's diagnosed

Diagnosis relies on recognizing the overall clinical pattern rather than any single test. The ASAS (Assessment of SpondyloArthritis International Society) classification criteria formalize this approach for people under 45 with three or more months of back pain: a diagnosis is supported by either imaging evidence of sacroiliitis (on X-ray or MRI) plus at least one additional spondyloarthritis feature, or a positive HLA-B27 test plus two or more supporting features such as inflammatory back pain, good response to NSAIDs, a family history of spondyloarthritis, psoriasis, inflammatory bowel disease, uveitis, enthesitis, or elevated inflammatory markers.

Imaging plays a central role. Plain X-rays of the pelvis can show established sacroiliitis, but changes may take years to appear. MRI of the sacroiliac joints is far more sensitive for early, active inflammation (bone marrow edema) before any permanent structural damage is visible on X-ray, which is why MRI has become key to catching the disease at its earliest, most treatable stage.

Laboratory testing typically includes HLA-B27 and inflammatory markers such as ESR and CRP. These support the diagnosis but are not required on their own: a negative HLA-B27 does not rule out the disease, and normal inflammatory markers do not exclude active disease either. Because the diagnostic journey has historically taken years, primary care clinicians, physical therapists, and spine specialists are increasingly trained to recognize the inflammatory back pain pattern early and refer promptly to rheumatology.

Treatment options

Treatment follows a stepwise approach guided by rheumatology (ACR/SAA/SPARTAN) recommendations. NSAIDs are the first-line therapy, and a large majority of patients get meaningful relief with continuous (rather than as-needed) dosing. Physical therapy and a structured exercise program, particularly spinal extension and mobility exercises, are recommended for everyone with the condition, alongside patient education and, when relevant, smoking cessation, since smoking is associated with faster disease progression.

For people whose disease remains active despite NSAIDs, biologic therapy is the next step. TNF inhibitors are typically tried first, and IL-17 inhibitors are an effective alternative or second-line option, including for patients who cannot use TNF inhibitors because of heart failure or a demyelinating condition. These medications target the underlying immune-driven inflammation directly, rather than simply masking pain, and starting them before structural damage accumulates is a major reason why early diagnosis matters so much. Conventional disease-modifying drugs used in other forms of arthritis, such as methotrexate, are generally not effective for the axial (spine) symptoms of this condition, though they can help peripheral joint involvement.

When surgery is considered

Surgery has a limited and specific role in inflammatory spondyloarthropathy. It is not used to treat the underlying inflammation, which responds to medical therapy, but it can address the structural consequences of long-standing disease. Spinal osteotomy may be considered for patients who have developed severe fixed forward stooping (kyphotic deformity) that impairs the ability to look forward and function, once the disease is under medical control. Because a fused, brittle spine fractures more easily than a normal one, even after a low-energy fall, urgent spine surgery is sometimes needed to stabilize an unstable fracture in someone with advanced disease. Hip replacement may also be considered when the disease has significantly damaged the hip joints. Outside of these structural and traumatic scenarios, the primary treatment strategy remains medical management directed by rheumatology.